The Post-ICU Pain Study
PIP
1 other identifier
observational
800
1 country
4
Brief Summary
BACKGROUND: ICU survivors may experience serious psychological, physical and cognitive impairments following ICU admission, collectively termed Post Intensive Care Syndrome (PICS). Persistent pain is an underrecognized component of PICS. Previous research has shown that persistent pain is a profound clinical challenge in ICU survivors, however, research demonstrates conflicting results. Furthermore, no studies have examined the prevalence of persistent pain in ICU survivors in a contemporary Danish ICU setting. OBJECTIVES: We aim to examine the clinical trajectory, risk factors, and pathophysiology of persistent pain in ICU survivors in Denmark. DESIGN AND SAMPLE SIZE: The study is designed as a multicenter, prospective, inception cohort study with clinical follow-up. Based on the pre-study sample size calculation, 800 patients will be included. Patients will be contacted by telephone 90 days and 180 days after ICU discharge, and a series of questionnaires regarding pain, sleep quality, affective state and quality of life will be completed. A subgroup of patients will undergo a detailed clinical examination including quantitative sensory testing between 180-365 days after ICU discharge. POPULATION: Patients will be recruited from 4 Danish ICU departments. Inclusion criteria include adult patients (18 years of age), acute admission to the ICU, and an ICU admission of a minimum of 48 hours. OUTCOMES: The primary outcome is the prevalence of pain assessed by the Brief Pain Inventory (BPI) at 90 and 180 days after ICU discharge. Secondary outcomes include additional detailed descriptions of pain and daily activity, sleep quality, affective state, quality of life, treatment- and patient-related risk factors, and biomarkers associated with development of persistent pain. Substudies: \- QST substudy: 80 participants (40 with pain and 40 without pain) recruited from the main cohort will undergo Quantative Somatosensory Testing (QST). The objectives are first, to delineate somatosensory profiles of ICU survivors with and without pain, and second, to examine the presence of neuropathic pain in ICU survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2025
CompletedFirst Posted
Study publicly available on registry
September 18, 2025
CompletedStudy Start
First participant enrolled
September 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
December 2, 2025
September 1, 2025
1.3 years
July 15, 2025
November 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of pain
Patients are defined as having pain if they answer "yes" to question number 1 in the Brief Pain Inventory - Short Form
180 day follow-up
Secondary Outcomes (9)
Brief Pain Inventory - Short Form (BPI-SF)
At follow-up at 90 and 180 days
Incidence of new-onset persistent pain after ICU discharge
at 90 and 180 days follow-up
Quality of life measured by EuroQol-5-domain 5-level (EQ-5D-5L)
at 90 and 180 days
The Single Item Sleep Quality Scale (SQS)
at 90 and 180 days
Hospital Anxiety and Depression Scale (HADS)
at 90 and 180 days
- +4 more secondary outcomes
Other Outcomes (7)
The Short Physical Performance Battery (SPPB)
between 180 days followup and 360 days.
PainDETECT (PD-Q)
between 180 days followup and 360 days
QST outcomes
between 180 days followup and 360 days
- +4 more other outcomes
Eligibility Criteria
Patients admitted to the ICU
You may qualify if:
- Adult ICU patients ≥18 years of age
- Acute admission to the ICU
- ICU length of stay of at least 48 hours
You may not qualify if:
- Patients transferred from a non-participating ICU
- Patients with pre-planned admission to the ICU e.g., following elective surgery
- Patients unable to complete questionnaires, including those who are unable to understand or speak Danish, or patients with severe cognitive deficits.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zealand University Hospitallead
- Aalborg University Hospitalcollaborator
Study Sites (4)
Aalborg University Hospital
Aalborg, 9000, Denmark
Zealand University Hospital
Køge, 4600, Denmark
Zealand University Hospital
Nykøbing Falster, 4800, Denmark
Zealand University Hospital
Roskilde, 4000, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 15, 2025
First Posted
September 18, 2025
Study Start
September 23, 2025
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
December 2, 2025
Record last verified: 2025-09